期刊文献+

干燥性角结膜炎应用普拉洛芬滴眼液治疗的临床研究 被引量:4

To Investigate the Clinical Efficacy of Pilocarpine Eye Drops in the Treatment of Dry Keratoconjunctivitis
下载PDF
导出
摘要 目的观察并探讨普拉洛芬滴眼液治疗干燥性角结膜炎临床疗效。方法选取我院2016年2月至2017年2月期间门诊就诊并治疗的80例确诊为干燥性角结膜炎的患者为研究对象,随机分为实验组40例和对照组40例。实验组给予聚乙烯醇滴眼液联合普拉洛芬滴眼液治疗,对照组给予聚乙烯醇滴眼液治疗。对比两组患者临床效果及泪膜破裂时间。结果经两种方法治疗后,实验组的总有效率明显高于对照组(92.50%VS 75%)。对照组主观症状平均评分明显低于对照组,实验组的泪膜破裂时间明显比对照组延长。结论普拉洛芬滴眼液治疗干燥性角结膜炎的临床效果显著,能够明显改善患者的临床症状,值得在临床上推广。 Objective To observe and explore the clinical efficacy of pramlofen eye drops in the treatment of dry keratoconjunctivitis.Methods Eighty patients with dry keratoconjunctivitis were randomly divided into experimental group(n=40)and control group(n=40).The patients were randomly divided into experimental group(n=40).The rats in the experimental group were treated with polyvinyl alcohol eye drops and prazolafine eye drops.The control group was treated with polyvinyl alcohol eye drops.Comparison of two groups of patients with clinical effects and tear film rupture time.Results The total effective rate of the experimental group was significantly higher than that of the control group(92.50% vs 75%)after treatment by two methods.The average score of the subjective symptoms in the control group was significantly lower than that in the control group.The tear film rupture time in the experimental group was significantly longer than that in the control group.Conclusion The clinical effect of pramlofen eye drops on the treatment of dry keratoconjunctivitis is remarkable,which can obviously improve the clinical symptoms of patients and is worthy of clinical promotion.
作者 王淑兰
出处 《内蒙古医学杂志》 2017年第8期907-909,共3页 Inner Mongolia Medical Journal
关键词 干燥性角结膜炎 普拉洛芬滴眼液 dry keratoconjunctivitis pranoprofen eye drops
  • 相关文献

参考文献5

二级参考文献38

  • 1费文雷,陈家祺,王智崇,陈龙山,孙明霞.FK506局部治疗顽固性春季角结膜炎[J].中国实用眼科杂志,2004,22(11):916-918. 被引量:18
  • 2邵仲英,谭玲,封宇飞.H_1受体拮抗剂的不良反应及合理应用[J].药物不良反应杂志,2006,8(1):30-32. 被引量:13
  • 3史伟云,刘廷,谢立信,王身国.FK506缓释系统前房植入抑制兔高危角膜移植术后的免疫排斥反应[J].中华眼科杂志,2006,42(4):299-304. 被引量:18
  • 4Sakuma S, Higashi Y, Soato N, et al. Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system ( Comparison with steroids ). lnt Immunopharma~ol 2001 ; 1 ( 6 ) : 1219-1226.
  • 5韩锐,贾立华,刘泽源,等.几种常见免疫抑制剂的研究进展.药学专论,2011;20(13):1-4.
  • 6Peters DH, Fitton A, Plosker GL, et al. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation. Drugs 1993 ;46(4) :746-794.
  • 7Atlas-fox L, Barkana Y, Iskhakov V, et al. Topical lacrolimus 0.03% onitment for intractable allergic conjunctivitis:an open-label pilot study. Curr Eye Res 2008 ;33(7) :545-549.
  • 8Uchio E., Ono SY, Ikezawa Z, et al. Tear levels of interferon-gamma, interleukin ( IL ) -2, IL- 4 and IL- 5 in patients with vernal keratoeonjunctivitis, atopic keratoeonjunctivitis and allergic conjunctivitis. Clin Exp Allerg 2000 ; 30 ( 1 ) : 103 - 109.
  • 9Bonini S, Bonini S, Lambiase A, et al . Vernal keratoconjunctivitis revisited: a case series of 195 patients with long- term followup. Ophthalmology 2000 ; 107 ( 6 ) : 1157-1163.
  • 10Marey HM, Mandour SS, E1 Morsy OA, et al. Impact of vernal keratoconjunctivitis on school children in Egypt. Semin Ophthalmol 2016[ Epub ahead of print].

共引文献30

同被引文献25

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部